PRAs bring expertise and passion to study on access to HIV care

Tim Wesseling and Sean Grieve are approachable, engaging and affable; more importantly, they are passionate and dedicated to making a difference in their communities. Both are peer research associates (PRAs) on the BC-CfE’s STOP HIV/AIDS¨ Program Evaluation (SHAPE) study, which aims to uncover what factors influence individuals’ access HIV health care and how people can best be supported to stay engaged in care.

Read More »

Here’s what happened at CROI

Top researchers from around the world gathered in Seattle last week to share the latest in the ongoing battle against HIV/AIDS and related infectious diseases. The annual Conference on Retroviruses and Opportunistic Infections (CROI) is the preeminent HIV research meeting and attracts more than 4,000 HIV/AIDS research leaders. Among them were scientists from the BC-CfE, who presented research on PrEP, HIV and aging, phylogenetics and more.

Read More »

BC-CfE research presented at the CROI 2019 conference

The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.

Read More »

Teams from across the province share ideas to BOOST engagement in lifesaving OAT

BC-CfE’s provincial BOOST Collaborative is following on the heels of the successful Vancouver-based BOOST Collaborative. BOOST is inspired by the made-in-BC Treatment as Prevention¨ strategy and supports a Targeted Disease Elimination¨ (TDE¨ ) approach. This means using tools and strategies that have been proven through the work of the BC-CfE in curbing HIV transmissions. The TDE¨ strategy can address contagious diseases and diseases with a social contagion factor, such as substance use disorders.

Read More »
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below